Abstract

Over the last decade, the Indian pharmaceutical market experienced remarkable growth.This growth can be measured in increased patentchallenge activity, regulatory filings, mergers andacquisitions. To stay competitive and encourage futuregrowth, Indian API companies are broadening their scopeof capabilities, shifting their focus from simply supplying lowcostAPIs to being fully integrated providers capable ofoffering more amenities and increasingly pursuing thedevelopment of innovative generics, biotechnology/biosimilars and niche molecules. Future growth in the Indianpharmaceutical market may come through furtherconsolidation and marketing tie-ups with multinationalcompanies, while some companies may drive growth byinvesting in a sales force to promote their products in thelocal market.